A Life Science Consulting expert claims that half of Indian pharmaceutical companies could lose their US market share because many cannot meet by November 2017 the medicine traceability mandates set down by the US Drug Supply Chain Security Act (DSCSA) in 2013.
Source : www.securingindustry.com